Wei Wang1, Yan Shao2, Shenhua Tang1, Xianyong Cheng1, Haifeng Lian1, Chengyong Qin3. 1. Department of Gastroenterology, The Affiliated Hospital of Binzhou Medical University Binzhou 256603, Shandong, China. 2. Department of Life Sciences, Binzhou University Binzhou 256603, Shandong, China. 3. Department of Gastroenterology, Shandong Pronvicial Hospital, Shandong University Jinan 250021, Shandong, China.
Abstract
BACKGROUND: The association between the peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk was inconclusive. We conducted a meta-analysis to evaluate the association between PPARγ Pro12Ala polymorphism and CRC risk. MATERIAL AND METHOD: We searched Pubmed, EMBASE, and China National Knowledge Infrastructure databases. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated. RESULTS: A total of 17 case-control studies with 12635 and 15803 controls were included in this meta-analysis. Overall, PPARγ Pro12Ala polymorphism was associated with CRC risk (OR = 0.84, 95% CI 0.75-0.94, P = 0.003, I(2) = 35%). In the subgroup analysis by ethnicity, a significant association was found among Caucasians (OR = 0.85, 95% CI 0.75-0.96, P = 0.007, I(2) = 38%) but not among Asians (OR = 0.76, 95% CI 0.51-1.12, P = 0.17, I(2) = 28%). In the subgroup analysis by CRC site, a significant association was found among colon cancer (OR = 0.81, 95% CI 0.66-0.98, P = 0.03, I(2) = 16%) but not among rectal cancer (OR = 0.83, 95% CI 0.57-1.21, P = 0.34, I(2) = 63%). The sensitivity analysis did not influence the result by omitting low-quality studies (OR = 0.76, 95% CI 0.63-0.93, P = 0.006, I(2) = 51%). CONCLUSIONS: In conclusion, this meta-analysis suggested that PPARγ Pro12Ala polymorphism was significant associated with CRC risk.
BACKGROUND: The association between the peroxisome proliferator-activated receptor-γ (PPARγ) Pro12Ala polymorphism and colorectal cancer (CRC) risk was inconclusive. We conducted a meta-analysis to evaluate the association between PPARγ Pro12Ala polymorphism and CRC risk. MATERIAL AND METHOD: We searched Pubmed, EMBASE, and China National Knowledge Infrastructure databases. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated. RESULTS: A total of 17 case-control studies with 12635 and 15803 controls were included in this meta-analysis. Overall, PPARγ Pro12Ala polymorphism was associated with CRC risk (OR = 0.84, 95% CI 0.75-0.94, P = 0.003, I(2) = 35%). In the subgroup analysis by ethnicity, a significant association was found among Caucasians (OR = 0.85, 95% CI 0.75-0.96, P = 0.007, I(2) = 38%) but not among Asians (OR = 0.76, 95% CI 0.51-1.12, P = 0.17, I(2) = 28%). In the subgroup analysis by CRC site, a significant association was found among colon cancer (OR = 0.81, 95% CI 0.66-0.98, P = 0.03, I(2) = 16%) but not among rectal cancer (OR = 0.83, 95% CI 0.57-1.21, P = 0.34, I(2) = 63%). The sensitivity analysis did not influence the result by omitting low-quality studies (OR = 0.76, 95% CI 0.63-0.93, P = 0.006, I(2) = 51%). CONCLUSIONS: In conclusion, this meta-analysis suggested that PPARγ Pro12Ala polymorphism was significant associated with CRC risk.
Authors: Louise E McGreavey; Faye Turner; Gillian Smith; Katherine Boylan; D Timothy Bishop; David Forman; C Roland Wolf; Jennifer H Barrett Journal: Pharmacogenet Genomics Date: 2005-10 Impact factor: 2.089
Authors: Martha L Slattery; Roger K Wolff; Karen Curtin; Frank Fitzpatrick; Jennifer Herrick; John D Potter; Bette J Caan; Wade S Samowitz Journal: Mutat Res Date: 2008-10-15 Impact factor: 2.433
Authors: S S Deeb; L Fajas; M Nemoto; J Pihlajamäki; L Mykkänen; J Kuusisto; M Laakso; W Fujimoto; J Auwerx Journal: Nat Genet Date: 1998-11 Impact factor: 38.330
Authors: Fränzel J B van Duijnhoven; H Bas Bueno-De-Mesquita; Pietro Ferrari; Mazda Jenab; Hendriek C Boshuizen; Martine M Ros; Corinne Casagrande; Anne Tjønneland; Anja Olsen; Kim Overvad; Ole Thorlacius-Ussing; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Sophie Morois; Rudolf Kaaks; Jakob Linseisen; Heiner Boeing; Ute Nöthlings; Antonia Trichopoulou; Dimitrios Trichopoulos; Gesthimani Misirli; Domenico Palli; Sabina Sieri; Salvatore Panico; Rosario Tumino; Paolo Vineis; Petra Hm Peeters; Carla H van Gils; Marga C Ocké; Eiliv Lund; Dagrun Engeset; Guri Skeie; Laudina Rodríguez Suárez; Carlos A González; María-José Sánchez; Miren Dorronsoro; Carmen Navarro; Aurelio Barricarte; Göran Berglund; Jonas Manjer; Göran Hallmans; Richard Palmqvist; Sheila A Bingham; Kay-Tee Khaw; Timothy J Key; Naomi E Allen; Paolo Boffetta; Nadia Slimani; Sabina Rinaldi; Valentina Gallo; Teresa Norat; Elio Riboli Journal: Am J Clin Nutr Date: 2009-04-01 Impact factor: 7.045
Authors: Ulla Vogel; Jane Christensen; Marianne Dybdahl; Søren Friis; Rikke D Hansen; Håkan Wallin; Bjørn A Nexø; Ole Raaschou-Nielsen; Paal S Andersen; Kim Overvad; Anne Tjønneland Journal: Mutat Res Date: 2007-04-27 Impact factor: 2.433